These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12264797)

  • 1. Clinical experience with intramuscular norethisterone oenanthate as a contraceptive.
    Howard G; Blair M; Fotherby K; Howell R; Elder MG; Bye P
    J Obstet Gynaecol (Lahore); 1980; 1(1):53-8. PubMed ID: 12264797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Howard G; Blair M; Chen JK; Fotherby K; Muggeridge J; Elder MG; Bye PG
    Contraception; 1982 Apr; 25(4):333-40. PubMed ID: 7049569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Return of fertility in women discontinuing injectable contraceptives.
    Fotherby K; Howard G
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraceptive efficacy of norethindrone acetate (ENTA) implant: its release rate and fertility potential.
    Shahani SM; Kulkarni PP; Laumas KR
    J Obstet Gynaecol India; 1983 Feb; 33(1):16-20. PubMed ID: 12265592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trial of a long-acting injectable contraceptive: NET-EN.
    Chaudhuri C; Mukherjea M
    Contracept Deliv Syst; 1984 Jan; 5(1):47-52. PubMed ID: 12312744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: noresthisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects.
    Contraception; 1978 May; 17(5):395-406. PubMed ID: 657807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two years' clinical experience with norethisterone enanthate as a prolonged-action injectable contraceptive].
    Larranaga A; Kesseru E
    Ginecol Obstet (Lima); 1968 Aug; 14(2):209-21. PubMed ID: 12305607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraception for the older woman.
    Guillebaud J
    J Obstet Gynaecol (Lahore); 1985 Jan; 5 Suppl 2():S70-7. PubMed ID: 12268772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study on injectable contraceptive Noristerat.
    Chowdhury TA
    Bangladesh Med J; 1985; 14(2-3):28-35. PubMed ID: 12268850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical and metabolic study of norethisterone oenanthate in Thai women.
    Virutamasen P; Nitichai Y; Tangkeow P; Kankeerati W; Rienprayura D; Boonsiri B
    Contraception; 1980 Oct; 22(4):397-408. PubMed ID: 7449388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase IV study of the injection Norigest in Pakistan.
    Kazi A; Holck SE; Diethelm P
    Contraception; 1985 Oct; 32(4):395-403. PubMed ID: 3907968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting injectable norethisterone contraceptive system: review of clinical studies.
    Beck LR; Pope VZ
    Res Front Fertil Regul; 1984 Dec; 3(2):1-10. PubMed ID: 12179635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norethisterone oenanthate as an injectable contraceptive in two treatment schedules in interval subjects.
    Gulati K; Mapa MK; Gupta AN; Singh PM; Devi PK
    Asia Oceania J Obstet Gynaecol; 1984 Sep; 10(3):281-6. PubMed ID: 6525083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Norethisterone enanthate as an injectable contraceptive in puerperal and non-puerperal women.
    Melis GB; Strigini F; Fruzzetti F; Paoletti AM; Rainer E; Düsterberg B; Fioretti P
    Contraception; 1981 Jan; 23(1):77-88. PubMed ID: 6781816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I
    Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications and medical survey of long acting progestatives used for contraception (author's transl)].
    Molitor-peffer MP
    Contracept Fertil Sex (Paris); 1982 Oct; 10(10):665-8. PubMed ID: 12338449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.